Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
- 2 February 2005
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 134A (2) , 144-150
- https://doi.org/10.1002/ajmg.a.30579
Abstract
Stuart J. Swiedler, Michael Beck, Manal Bajbouj, Roberto Giugliani, Ida Schwartz, Paul Harmatz, James E. Wraith, Jane Roberts, David Ketteridge, John J. Hopwood, Nathalie Guffon, M. Clara Sá Miranda, Elisa Leão Teles, Kenneth I. Berger, Cheri Piscia-NicholKeywords
Funding Information
- BioMarin Pharmaceutical, Inc.
- National Center for Research Resources (5 M01 RR-01271)
- U.S. Public Health Service
This publication has 31 references indexed in Scilit:
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)The Journal of Pediatrics, 2004
- Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfataseHuman Mutation, 2001
- The clinical meaning of functional outcome scores in children with juvenile arthritisArthritis & Rheumatism, 2001
- Enzyme-Replacement Therapy in Mucopolysaccharidosis INew England Journal of Medicine, 2001
- Urinary Glycosaminoglycan Excretion in Healthy Subjects and in Patients with MucopolysaccharidosesArchives of Medical Research, 2000
- Bone marrow transplantation for Maroteaux–Lamy syndrome (MPS VI): Long‐term follow‐upJournal of Inherited Metabolic Disease, 1999
- Self-Selected Walking Velocity for Functional Ambulation in Patients With End-Stage EmphysemaJournal of Cardiopulmonary Rehabilitation, 1997
- Allogeneic bone marrow transplantation for lysosomal storage diseasesThe Lancet, 1995
- An update on the frequency of mucopolysaccharide syndromes in British ColumbiaHuman Genetics, 1990
- Clinical Measurement of Range of MotionPTJ: Physical Therapy & Rehabilitation Journal, 1987